The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 748K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

8 articles for JB Monahan


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Discovery of PH-797804, a highly selective and potent inhibitor of p38 MAP kinase.EBI
Pfizer
Discovery of N-substituted pyridinones as potent and selective inhibitors of p38 kinase.EBI
Pfizer
Design, synthesis and activity of a potent, selective series of N-aryl pyridinone inhibitors of p38 kinase.EBI
Pfizer
Substituted N-aryl-6-pyrimidinones: a new class of potent, selective, and orally active p38 MAP kinase inhibitors.EBI
Pfizer
Identification of SD-0006, a potent diaryl pyrazole inhibitor of p38 MAP kinase.EBI
Pfizer
Picolinamido-propanoic acid derivatives useful as glucagon receptor antagonistsBDB
Janssen Pharmaceutica
Decreased binding affinity of olanzapine and clozapine for human muscarinic receptors in intact clonal cells in physiological medium.BDB
Eli Lilly
1-Azakenpaullone is a selective inhibitor of glycogen synthase kinase-3 beta.BDB
Technische Universitat Braunschweig